Medicare Procedure and Patient Information
2020 Medicare Patient Data
Information about Medicare patients treated by Mason Dyess.
| Non-Hispanic White | |
|---|---|
| Black | |
| Hispanic | |
| Asian | |
| Other | |
| Native American |
(No ratings)
Mason Dyess is a neurologist in Seattle, WA specializing in neurology (brain & spinal cord disease). Mason Dyess is affiliated with BHS PHYSICIANS NETWORK INC.
Information about Medicare patients treated by Mason Dyess.
| Non-Hispanic White | 19 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
Volume of procedures performed by Mason Dyess for Medicare patients.
| doctor visit | 109 |
|---|
Information about Medicare patients treated by Mason Dyess.
| Male | 44 |
|---|---|
| Female | 70 |
| Non-Hispanic White | 83 |
|---|---|
| Black | 19 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 53 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 29 |
The most common conditions of Medicare patients that Mason Dyess treated during 2021 were hypertension, high cholesterol, depression and chronic kidney disease.
| Hypertension | 73 |
|---|---|
| High Cholesterol | 65 |
| Stroke | 0 |
| Ischemic Heart Disease | 24 |
| Depression | 46 |
| Chronic Kidney Disease | 37 |
| Asthma | 13 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 11 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 11 |
| Diabetes | 28 |
| Dementia | 22 |
| Cancer | 0 |
The top procedures that Mason Dyess treated as a neurologist in Seattle, WA during 2022 were hospital care and inpatient care.
Volume of procedures performed by Mason Dyess for Medicare patients.
| doctor visit | 136 |
|---|---|
| hospital care | 14 |
| inpatient care | 14 |
Information about Medicare patients treated by Mason Dyess.
| Male | 66 |
|---|---|
| Female | 95 |
| Non-Hispanic White | 98 |
|---|---|
| Black | 42 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 73 |
|---|---|
| From 75 to 84 | 44 |
| 85 and over | 21 |
| Less than 65 | 23 |
The most common conditions of Medicare patients that Mason Dyess treated during 2022 were high cholesterol, hypertension, chronic kidney disease and diabetes.
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 21 |
| Ischemic Heart Disease | 29 |
| Depression | 32 |
| Chronic Kidney Disease | 35 |
| Asthma | 9 |
| Osteoperosis | 15 |
| Atrial Fibrilation | 12 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 17 |
| Diabetes | 34 |
| Dementia | 25 |
| Cancer | 16 |
The top procedures that Mason Dyess treated as a neurologist in Seattle, WA during 2023 were hospital care and inpatient care.
Volume of procedures performed by Mason Dyess for Medicare patients.
| doctor visit | 142 |
|---|---|
| hospital care | 11 |
| inpatient care | 11 |
Information about Medicare patients treated by Mason Dyess.
| Male | 63 |
|---|---|
| Female | 111 |
| Non-Hispanic White | 110 |
|---|---|
| Black | 47 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 70 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 21 |
| Less than 65 | 34 |
The most common conditions of Medicare patients that Mason Dyess treated during 2023 were high cholesterol, hypertension, depression and diabetes.
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 16 |
| Ischemic Heart Disease | 25 |
| Depression | 36 |
| Chronic Kidney Disease | 30 |
| Asthma | 9 |
| Osteoperosis | 18 |
| Atrial Fibrilation | 15 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 31 |
| Dementia | 16 |
| Cancer | 11 |
Volume of procedures performed by Mason Dyess for Medicare patients.
The highest averages for the top procedures that Mason Dyess treated as a neurologist in Seattle, WA were hospital care and inpatient care.
| doctor visit | 129 |
|---|---|
| hospital care | 12 |
| inpatient care | 12 |
Information about Medicare patients treated by Mason Dyess.
| Male | 43 |
|---|---|
| Female | 69 |
| Black / African American | 27 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 77 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 23 |
|---|---|
| 85 and over | 10 |
| Less than 65 | 21 |
| 65 to 74 | 49 |
The highest averages of the most common conditions of Medicare patients that Mason Dyess treated were hypertension, high cholesterol, depression and chronic kidney disease.
| Hypertension | 55 |
|---|---|
| High Cholesterol | 53 |
| Stroke | 9 |
| Ischemic Heart Disease | 19 |
| Depression | 28 |
| Chronic Kidney Disease | 25 |
| Asthma | 7 |
| Osteoporosis | 11 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 23 |
| Atrial Fibrillation | 9 |
| Dementia | 15 |
| Cancer | 6 |
He has a state license in Louisiana.
Licensed In: Louisiana
Mason Dyess is associated with these hospitals and organizations:
Mason Dyess does not have any reviews yet, be the first to leave a review of Mason Dyess here: Leave a Review
(No ratings)
These charts describe general payments received by Mason Dyess. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Sunovion Pharmaceuticals Inc. |
$479
LATUDA $354 |
APTIOM $125 |
||||
|---|---|---|---|---|---|---|
| UCB, Inc. |
$421
Briviact $231 |
Vimpat $190 |
||||
| AbbVie Inc. |
$219
UBRELVY $158 |
BOTOX $46 |
QULIPTA $14 |
|||
| ACADIA Pharmaceuticals Inc |
$201
NUPLAZID $201 |
|||||
| Allergan Inc. |
$164
VRAYLAR $148 |
BOTOX CHRONIC MIGRAINE $17 |
||||
| Other |
$624
Xadago $158 |
AUSTEDO $125 |
INGREZZA $100 |
Gilenya $70 |
NURTEC ODT $64 |
Other $107 |
| Food and Beverage | $2,108 |
|---|
Dr. Mason Dyess has obtained a license to practice in Washington.